Drug Development

Articles

Hovione Technology has acquired global rights to a dry powder inhaler for pulmonary drug delivery, the Papillon DPI invented by Dr. Klaus-Dieter Beller.

Hovione Technology Acquires Rights to New Blister-Based Inhaler

EMA is evaluating the safety of Lemtrada (alemtuzumab) after new side effects were reported.

EMA Reviews Safety of Alemtuzumab

Agnes Shanley is senior editor of Pharmaceutical Technology.

At INTERPHEX 2019, CEO Richard Johnson highlighted the importance of PDA’s new Asian business unit and outlined the organization’s plans. Data integrity guidance for manufacturing and quality systems will be published by the end of the year, as efforts move into big data and artificial intelligence.

PDA Strengthens its Global Presence

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Patient-centric drug development is becoming more important in the bio/pharma industry.

Designed with the Patient in Mind

Catalent invests $5 million in hot melt extrusion capabilities at Somerset, NJ facility. 

Catalent Expands HME Capabilities

3M Drug Delivery Systems UK organization has revealed that it is relocating its R&D team to the Charnwood Campus, which is an officially designated Life Sciences Opportunity Zone in Loughborough, United Kingdom

3M Relocates R&D to Life Sciences Opportunity Zone in Loughborough, UK

Novartis’ Sandoz resubmitted its biologics license application (BLA) for a proposed biosimilar pegfilgrastim to FDA in response to a 2016 complete response letter from the agency.

Sandoz Resubmits BLA for Biosimilar to Amgen’s Neulasta

Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.

Biologic Drug Manufacturing Capacity on the Agenda for INTERPHEX 2019 Keynote Series

The acquisition is expected to expand CURE Pharmaceutical’s technology platform in oral drug delivery.

CURE Pharmaceutical to Acquire Chemistry Holdings

Characterizing particles and understanding bulk powder behavior is critical to get the best pharma product.


Formulation and Drug Delivery